Health
China’s Covid-19 vaccine candidate proves safe in initial tests – Hindustan Times
Scientists have said that despite the vaccine proving safe, no data to establish the final efficacy.
Researchers in China have confirmed that BBIBP-CorV, a vaccine currently under human trial observation, has safely triggered the expected antibody immune responses.
The combined early and mid-stage trials for the vaccine happened between April 29 and July 30 this year.
Beijing Institute of Biological Products, a subsidiary of China National Biotec Group (CNBG), is currently developing the vaccine. It is one of ten potential vaccine candidates that have entered the Phase III trials around the …
-
General22 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
Noosa News21 hours agoFarmers call for policy reform across multiple sectors as productivity collapses
-
Noosa News22 hours agoQueensland Premier David Crisafulli keeps clear of Coalition chaos in Canberra
-
Noosa News18 hours agoTrump’s trade war puts Australian beef centre stage in Shanghai